D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Nike
NKE
$61.9B
| $9.13M | 0.01% |
108,384
+22,444
| +26% | +$1.85M |
|
1127
Magnite
MGNI
$2.65B
| $9.12M | 0.01% |
1,500,514
+259,125
| +21% | +$1.33M |
|
1128
Calix
CALX
$2.27B
| $9.12M | 0.01% |
1,184,371
-81,116
| -6% | -$715K |
|
1129
Regis Corp
RGS
$69.9M
| $9.1M | 0.01% |
23,125
-4,863
| -17% | -$1.8M |
|
1130
CALL
Kohl's
KSS
$2.03B
| $9.08M | 0.01% |
132,000
-23,900
| -15% | -$1.62M |
|
1131
Axalta
AXTA
$7.01B
| $9.06M | 0.01% |
359,274
+304,692
| +558% | +$7.84M |
|
1132
PUT
Alcoa
AA
$11.7B
| $9.05M | 0.01% |
321,300
-21,000
| -6% | -$601K |
|
1133
CALL
Trade Desk
TTD
$8.13B
| $9.05M | 0.01% |
457,000
+400,000
| +702% | +$6.55M |
|
1134
CALL
Domino's
DPZ
$11B
| $9.03M | 0.01% |
35,000
-52,400
| -60% | -$13.6M |
|
1135
CALL
Ubiquiti
UI
$31.8B
| $8.98M | 0.01% |
60,000
+30,000
| +100% | +$3.79M |
|
1136
Highwoods Properties
HIW
$3.71B
| $8.93M | 0.01% |
190,953
-116,877
| -38% | -$5.21M |
|
1137
Novartis
NVS
$295B
| $8.92M | 0.01% |
103,545
-703,162
| -87% | -$56.4M |
|
1138
PUT
EOG Resources
EOG
$78B
| $8.92M | 0.01% |
93,700
+67,500
| +258% | +$6.43M |
|
|
JCP
1139
DELISTED
J.C. Penney Company, Inc.
JCP
| $8.9M | 0.01% |
5,974,158
+5,944,971
| +20,369% | +$8.37M |
|
1140
Fortis
FTS
$30B
| $8.89M | 0.01% |
240,387
-131,120
| -35% | -$4.66M |
|
1141
Constellium
CSTM
$3.96B
| $8.87M | 0.01% |
1,111,342
+245,325
| +28% | +$2.1M |
|
1142
Archer Daniels Midland
ADM
$41.4B
| $8.87M | 0.01% |
+205,617
| New | +$8.79M |
|
1143
Unisys
UIS
$227M
| $8.86M | 0.01% |
759,434
-347,209
| -31% | -$4.48M |
|
|
MODN
1144
DELISTED
MODEL N, INC.
MODN
| $8.86M | 0.01% |
505,180
-36,270
| -7% | -$580K |
|
1145
Ingredion
INGR
$6.38B
| $8.83M | 0.01% |
93,266
+87,931
| +1,648% | +$8.31M |
|
1146
Interface
TILE
$1.91B
| $8.8M | 0.01% |
574,650
+9,137
| +2% | +$150K |
|
1147
PUT
Deere & Co
DE
$170B
| $8.76M | 0.01% |
54,800
-270,500
| -83% | -$43.2M |
|
1148
Bio-Techne
TECH
$11.2B
| $8.73M | 0.01% |
175,952
-134,236
| -43% | -$6.04M |
|
1149
HEICO Corp
HEI
$48.9B
| $8.73M | 0.01% |
92,047
+42,638
| +86% | +$3.72M |
|
1150
CALL
Boston Beer
SAM
$1.88B
| $8.72M | 0.01% |
29,600
+19,600
| +196% | +$5.36M |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.